Upgrade to SI Premium - Free Trial

SVB Leerink Downgrades Achillion Pharmaceuticals (ACHN) to Market Perform

October 18, 2019 4:27 AM
SVB Leerink analyst Joseph Schwartz downgraded Achillion Pharmaceuticals (NASDAQ: ACHN) from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst PT Change Downgrades